Genmab — December 2017
-
https://myelomaresearchnews.com/2016/10/05/amgens-kyprolis-fails-outperformance-velcade-newly-diagnosed-multiple-myeloma-patients/ Kyprolis fejlede i H2H imod Velcade i NDMM
-
Discovery's 'First In Human' Calls Much-Needed Attention To Clinical Trials
The new three-part documentary, which spotlights research at the National Institutes of Health’s (NIH) Building 10, has the potential to reverse misconceptions about participating in clinical trials.
Forbes (www.forbes.com)
-
-
-
-
Er der en venlig sjæl for vil forklare os uvidende om det er godt, skidt, fo
rventet eller ? -
Det ser ud til at Jan har noget at have sine 30 måneder i
-
Desuden bliver responserne dybere med tiden. Og skidtet kan gives uden problemer
-
@nohope takker og glæder mig over
det
️ -
The Future of Cancer Research
My Reflections from ASH 2017 This weekend, I have the pleasure of attending the 59th Annual American Society of Hematology (ASH) Meeting & Exhibition in Atlanta, GA, alongside many members of the Janssen Hematological Malignancies team. With more than 40 data presentations for both approved and inve
(www.linkedin.com)
-
Juno's JCAR017 data var gode, men ikke gode nok. Faldt 14% https://www.fool.com/investing/2017/12/11/whats-causing-juno-therapeutics-shares-to-tumble-1.aspx
-
det er i hvert fald noget der bakker op om JvdW udsagn om længere behandlingstid...Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind